Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other antipsychotics.
US FDA approves new schizophrenia drug
The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication that targets specific brain receptors without affecting dopamine pathways.
FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way. Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors. All other treatments available for schizophrenia target the dopamine receptors.
Experts hail new schizophrenia drug Cobenfy as a game-changer, the ‘first of its kind’
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer side effects British scientists have hailed the US approval of a new drug for schizophrenia,
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. This innovative medication marks a significant
Breakthrough in Schizophrenia Treatment: FDA Approves Cobenfy
New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.
BioSpace1h
The Making of BMS’ Cobenfy: From Alzheimer’s to Schizophrenia
From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...
Valley News Live21h
FDA approves new drug for schizophrenia, described as a potential ‘game changer’
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug ...
Coventry Telegraph1mon
Coventry drug addict told people his family were in hospital to get money
A Coventry man who persistently harassed his neighbours has been jailed. Ranjit Sadra would knock on doors at 3am asking for money and would aggressively beg in the streets around Cheylesmore.
Reuters18d
Neurocrine halts development of schizophrenia drug as trial fails
Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression drug candidates. Shares of the company were down 2.5% in extended trading.
BBC9mon
Coventry head teacher's concern at drug-dealing near school
A head teacher has expressed concern at drug-dealing happening near a school in Coventry. Residents close to the school and Charterhouse museum say dealing frequently takes place in the area.
Coventry Telegraph29d
Foleshill Road drug-drive crash leaves pedestrian with 'serious injuries'
A man has been left seriously injured following a 'hit-and-run' in Coventry. It happened yesterday evening (Sunday, September 1). He is alleged to have struck several vehicles and a pedestrian ...
Reuters1mon
Neurocrine's drug cuts schizophrenia symptoms in mid-stage study
Aug 28 (Reuters) - Neurocrine Biosciences (NBIX.O), opens new tab said on Wednesday its drug helped reduce the severity of schizophrenia symptoms in a mid-stage trial, but its shares fell nearly ...
Medscape4d
Reasons for Illicit Drug Use in People with Schizophrenia: Qualitative Study
Background: Drug misuse is an important clinical problem associated with a poorer outcome in patients who have a diagnosis of schizophrenia. Qualitative studies have rarely been used to elicit ...
ScienceAlert16h
First New Schizophrenia Treatment in Decades a Much-Needed Alternative
"This drug takes the first new approach to schizophrenia treatment in decades," Tiffany Farchione, a top official in the US ...